Structure via PubChem · Public domain (PubChem)
temoporfin
Sign in to saveAlso known as meso-tetrahydroxyphenylchlorin, 2,3-dihydro-5,10,15,20-tetra(m-hydroxyphenyl)porphyrin, m-THPC
Temoporfin (INN) is a photosensitizer (based on chlorin) used in photodynamic therapy for the treatment of squamous cell carcinoma of the head and neck. It is marketed in the European Union under the brand name Foscan. The U.S. Food and Drug Administration (FDA) declined to approve Foscan in 2000. The EU approved its use in June 2001.
In the Vinony graph
Vinony's link graph records 275 inbound references to temoporfin, and connects out to tiazofurin, European Union and digital object identifier.
It sits within the topics Chemical pages without DrugBank identifier, Drug has EMA link and Drugs with non-standard legal status.
Vinony links it to 6 Wikipedia language editions.
Chemical data
- Formula
- C44H32N4O4
- Molecular weight
- 680.7 g/mol
- IUPAC name
- 3-[10,15,20-tris(3-hydroxyphenyl)-2,3,22,24-tetrahydroporphyrin-5-yl]phenol
- SMILES
- C1CC2=NC1=C(C3=CC=C(N3)C(=C4C=CC(=N4)C(=C5C=CC(=C2C6=CC(=CC=C6)O)N5)C7=CC(=CC=C7)O)C8=CC(=CC=C8)O)C9=CC(=CC=C9)O
- InChIKey
- LYPFDBRUNKHDGX-UHFFFAOYSA-N
- XLogP
- 8.8
- Polar surface area
- 138 Ų
- H-bond donors
- 6
- H-bond acceptors
- 6
- Formal charge
- 0
via PubChem
Research
558 papersvia PubMed
Wikidata facts
- Subclass of
- chemical compound
- Mass
- 680.242355504
- Has use
- medication
Show 4 more facts
- chemical formula
- C₄₄H₃₂N₄O₄
- canonical SMILES
- C1CC2=NC1=C(C3=CC=C(N3)C(=C4C=CC(=N4)C(=C5C=CC(=C2C6=CC(=CC=C6)O)N5)C7=CC(=CC=C7)O)C8=CC(=CC=C8)O)C9=CC(=CC=C9)O
- NCI Thesaurus ID
- C1669
- subject has role
- photosensitizer
via Wikidata · CC0
~1 min read
Encyclopedic overview
2 sectionsContents
- References
- Further reading
Temoporfin (INN) is a photosensitizer (based on chlorin) used in photodynamic therapy for the treatment of squamous cell carcinoma of the head and neck. It is marketed in the European Union under the brand name Foscan. The U.S. Food and Drug Administration (FDA) declined to approve Foscan in 2000. The EU approved its use in June 2001.
Good results were obtained in 21 of 35 patients treated in Germany.
Excerpted from Wikipedia’s “temoporfin” article, available under the CC BY-SA 4.0 licence.